Latest Stock Split Details
Key information about Celltrion Pharm, Inc.'s most recent stock split
Split Date: 2024-12-27
Split Ratio: 21:20
Price Before Split: $58905.00
Price After Split: $56100.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.05 times more shares (a 21:20 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Celltrion Pharm, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-12-27 | 21:20 | No | $58905.00 | $56100.00 |
| 2023-12-27 | 21:20 | No | $91980.01 | $87600.01 |
| 2022-12-28 | 21:20 | No | $70980.01 | $67600.01 |
| 2021-12-29 | 103:105 | Yes | $92744.64 | $90978.07 |
| 2020-12-29 | 680:721 | Yes | $167634.12 | $158101.53 |
| 2019-12-27 | 5000:5253 | Yes | $25550.72 | $24320.12 |
| 2017-12-27 | 1020000:1158287 | Yes | $32523.51 | $28640.56 |
| 2016-12-28 | 262500:295363 | Yes | $10901.02 | $9688.14 |
| 2015-12-29 | 41200:49621 | Yes | $6361.12 | $5281.60 |
| 2014-12-29 | 1050000:1277741 | Yes | $2644.23 | $2172.93 |
About Celltrion Pharm, Inc.
Company overview and industry information
Celltrion Pharm, Inc. (068760.KQ) operates in the Drug Manufacturers - Specialty & Generic industry. The recent 21-for-20 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Drug Manufacturers - Specialty & Generic
Go to Celltrion Pharm, Inc. Summary